Around the world, COPD and lung cancer are major health problems on the rise on the rise. COPD is the fourth leading cause of death in the world and of lung cancer is the seventh, according to the World Health Organization .
Lung Cancer Diagnosis Aided by early detection of COPD, according to a new study, lung cancer in its early stages can be detected early by screening persons with chronic obstructive pulmonary disease . The study suggests that when clinicians can detect COPD at an earlier stage, this will also help to detect lung cancer at an early stage. The study is published online today in the European Respiratory Journal.The progress of first oral drug for the reducing relapses of MS.
Has approved the U.S. Food and Drug Administration Gilenya capsules recurrences relapses and delay in progression of disability in patients with relapsing multiple sclerosis . Gilenya, the first oral medication this the the progression of disabilities and reduce the frequency of and severity of symptoms in MS, offering patients an alternative to currently available injectable therapies are, Russell cat, Director Department for Neurology items to the FDA FDA Center for Drug evaluation and Research. The drug is used in 0.5 milligram capsules. Gilenya of Novartis, Switzerland.